comparemela.com

Latest Breaking News On - Genprex inc - Page 1 : comparemela.com

Genprex (NASDAQ:GNPX) Trading 1% Higher

Genprex, Inc. (NASDAQ:GNPX – Get Free Report) shares rose 1% on Wednesday . The company traded as high as $3.00 and last traded at $2.91. Approximately 119,449 shares traded hands during trading, an increase of 18% from the average daily volume of 101,125 shares. The stock had previously closed at $2.88. Analysts Set New Price […]

2022-2029 Forecast: Viral Vector Market Growth Trajectory In New Report

Viral Vector Market was worth USD 0.60 billion in 2022 and is estimated to grow at a CAGR of 19.7% in the forecasted period. The forecasted revenue hints at a growth of around 2.13 billion USD by 2029.

Genprex (NASDAQ:GNPX) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Genprex (NASDAQ:GNPX – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $10.00 price objective on the stock. Genprex Trading Up 0.8 % Shares of NASDAQ:GNPX traded up $0.02 on Wednesday, hitting $2.53. 38,029 shares of the company were exchanged, […]

Genprex (NASDAQ:GNPX) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Genprex (NASDAQ:GNPX – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. Genprex Stock Up 0.8 % Genprex stock traded up $0.02 during mid-day trading on Wednesday, hitting $2.53. 38,029 […]

Clinical Trials Commenced For Promising Acclaim-3 Reqorsa® Immunogene Therapy In Combination With Tecentriq® To Treat Small Cell Lung Cancer: Genprex,

Clinical Trials Commenced For Promising Acclaim-3 Reqorsa® Immunogene Therapy In Combination With Tecentriq® To Treat Small Cell Lung Cancer: Genprex,
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.